Introduction
Recent genetic studies, including meta-analyses of large-scale genome-wide association studies (GWAS), have successfully identified several genetic loci that influence asthma susceptibility, providing a better understanding of the pathogenesis of this complex disorder [1, 2] . However, only a small proportion of heritability can be explained by the previously identified single nucleotide polymorphisms (SNPs) associated with asthma [3, 4] . The missing heritability could partly reside in the phenotypic heterogeneity of asthma, not taken into account in genetic studies.
Asthma is a heterogeneous disease constituting separate overlapping syndromes probably with different, but as yet undefined, aetiologies and natural histories [5] . Childhood-and adult-onset asthma are among the most commonly accepted phenotypes. Interestingly, 17q21 genetic variants were specifically associated with childhood onset asthma in the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA), a result further confirmed by a large GWAS conducted within the GABRIEL consortium [1, 6] . Such results provided the first evidence for a genetic heterogeneity of asthma phenotypes. Unsupervised models aiming to identify homogeneous subgroups of subjects have been applied to unravel the phenotypic heterogeneity of asthma [7] . In adult asthma, these studies led to the identification of asthma phenotypes that exhibited differences in clinical response to treatment, in clinical, physiological and inflammatory parameters and in health-related quality of life [5, [8] [9] [10] . Although such refinement of asthma characterisation may shed light on asthma genetics, no genetic association studies have been conducted to date on asthma phenotypes defined by a clustering approach.
We aimed to identify genetic variants associated with cluster-derived asthma phenotypes in a large set of subjects recruited in three large epidemiological studies: the European Community Respiratory Health Survey (ECRHS), the Swiss Study on Air Pollution and Lung Disease in Adults (SAPALDIA) and the EGEA (comprising the ESE consortium).
Methods
Further information is provided in the online supplementary material.
Study populations
The ECRHS study is a European population-based study of young adults with an 8-year follow-up (ECRHSI (1991 8-year follow-up (ECRHSI ( -1993 ECRHSII (1999 ECRHSII ( -2002 , n510 933) [11] . SAPALDIA is a cohort study in the Swiss population initiated in 1991 (SAPALDIA1, n59651) with a follow-up assessment in 2002 (SAPALDIA2, n58047) [12] . The EGEA is a French case-control and family-based study with a 12-year follow-up investigation (EGEA1 (1991 (EGEA1 ( -1995 EGEA2 (2003 EGEA2 ( -2007 , n51601) [13] . Similar protocols, questionnaires and clinical examination were used in the three studies.
Cluster analysis in adult subjects with ever asthma In ECRHSII and SAPALDIA2, subjects with asthma answered positively to ''Have you ever had asthma?''. In EGEA2, asthma was defined by a positive answer to ''Have you ever had attacks of breathlessness at rest with wheezing?'' or ''Have you ever had asthma attacks?'' or being recruited as an asthma case in chest clinics.
In SAPALDIA and ECRHS the sample included in the genetic analysis represents a nested asthma casecontrol sample from the cohort (all subjects with asthma at baseline or follow-up with DNA and a random sample of controls).
The subjects were genotyped within the framework of the European GABRIEL consortium. Genotyping was carried out using the Human610 quad array (Illumina; San Diego, CA, USA), at the French national genotyping centre (Centre National de Genotypage, Evry, France). After quality control of genotyping, as previously described, the number of SNPs analysed was 499 138 [14] . The 39 candidate genetic loci included were those identified in previously published GWAS for asthma [1, 2, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . If the reported SNP was not genotyped in our data, the closest proxy (among SNPs in strong linkage disequilibrium (LD), assessed using a web-based tool (SNP Annotation and Proxy Search; www.broadinstitute.org/mpg/snap) with r 2 in the European Ancestry (CEU) panel of HapMap project) was used [25] .
Strategy of analysis
First, we aimed at identifying distinct adult asthma phenotypes by applying LCA, a latent variable model that serves to cluster subjects into classes, as previously used in ECRHS and EGEA [10] . Models with different numbers of latent classes were compared using the Bayesian information criterion (BIC) and when BIC were of similar magnitude on the phenotypes' prevalence (to avoid low-prevalent phenotypes in the prospective GWAS analysis). Each subject was assigned to the latent class for which they had the highest membership probability. To better characterise the phenotypes observed, smoking, treatment (in ECRHS and EGEA) and blood eosinophil and neutrophil counts (in EGEA) were compared between LCA-derived phenotypes.
Next, in order to identify genetic variants associated with specific asthma phenotypes, a genome-wide association analysis of each LCA-derived asthma phenotype compared to nonasthma controls was conducted. Genetic associations under a genetic additive model were assessed using a logistic regression model using robust sandwich estimation of the variance to model clustering of family genotypes, with adjustments for sex, study (ECRHS, SAPALDIA and EGEA) and informative principal components for within-Europe diversity (snpMatrix R package). The quantile-quantile plots are shown in online supplementary fig. E1 . l-values for phenotypes A, B, C and D were 1.10, 1.07, 1.11 and 0.95, respectively. On the basis of the effective number of independent markers for the adjustment of multiple testing, p,1.25610 -7 was considered as significant in the GWAS [26] . We also reported all SNPs indicating association signals, defined with two consecutive p-values ,10 -6 . We further investigated regions of ,20 kb upstream and downstream of these loci using the imputed genomic data (estimated by the MACH software (www.sph.umich.edu/csg/abecasis/MACH) and the HapMap2 Release 22 CEU reference sample). The regional association plot for each region was performed using LocusZoom (http://csg.sph.umich.edu/ locuszoom/). In addition, nonparametric Fisher tests are presented to account for the effect of low minor allele frequency in some SNPs (table E1) . To statistically compare the SNP effects across phenotypes, a test for heterogeneity was conducted using a multinomial regression model described in MORRIS et al. [27] . To better interpret our GWAS findings on specific asthma phenotypes in light of the largest asthma GWAS conducted so far on a simple asthma outcome, we provided the association observed in the meta-analysis in the GABRIEL study, after exclusion of the three ESE consortium studies, for each SNP identified in our GWAS. As a sensitivity analysis, we conducted the GWAS analysis using LCA probabilities (continuous outcomes), to address the robustness of our results to the outcomes definition. We also investigated the contribution of genetic loci identified for asthma by previous GWASs. In this candidate loci analysis, p,0.01 was considered significant, since only a priori defined candidate genetic loci were tested [28] .
Results
The population under study includes 3001 subjects with asthma (mean age 42.9 years; 44% male) and 3452 subjects without asthma (mean age 46.2 years; 48.9% male) (table 1). Half of the population reported childhood-onset asthma (age ,16 years). Current asthma treatment was reported by 45.2% of the population. In ECRHSII and EGEA2, 19% reported daily inhaled corticosteroid use at the time of the survey. The population participating in the genetic analysis comprised older subjects, more males, more asthmatics with early childhood-onset asthma and BHR compared to the population excluded from genetic analysis. A description of the asthmatic population for each survey is presented in table E1.
Asthma phenotypes identified by LCA
The four-class model was retained ( fig. E2 ). The mean highest posterior probability was high (82%), varying from 80% for phenotype D to 83% for phenotypes A and B, indicating that participants were assigned to classes with a fairly high probability. Phenotype A (18% of subjects), labelled ''inactive/mild nonallergic asthma'' was characterised by individuals with no or few asthma symptoms at the time of examination, low allergic disorders and BHR and high forced expiratory volume in 1 s (FEV1) ( fig. 1 and table 2). Phenotype B (37% of subjects), labelled ''inactive/mild allergic asthma'' was characterised by individuals with no or few symptoms at the time of examination but presenting with atopy and allergic disorders. Phenotype C (27% of subjects), labelled ''active allergic asthma'', was composed of younger individuals with childhood-onset asthma, atopy, asthma symptoms and BHR at examination. Phenotype D (18% of subjects), labelled ''active adult-onset nonallergic asthma'', was characterised by subjects reporting adult-onset asthma and asthma symptoms at examination, of whom few had atopy. Subjects belonging to phenotype D had an FEV1,80% predicted more often than the other groups. In the EGEA dataset, this last phenotype was significantly associated with higher blood neutrophil counts (geometric mean neutrophil counts were 3801 cells?mm -3 , 3584 cells?mm -3 , 3956 cells?mm -3 and 4626 cells?mm -3 for phenotypes A, B, C and D, respectively; p,0.0001).
The frequency of current smoking did not vary strongly across phenotypes (22.2-25 .8%); however, subjects included in phenotypes B and C, characterised by a younger age than phenotypes A and D, were more often never-smokers (table E2) . Subjects belonging to phenotypes A and B used asthma treatment in the past 3 months less often than others (table E2).
The total overall agreement between the latent classes identified and a simple classification defined by atopy status and asthma attacks in the past 12 months (two highly discriminative variables in the LCA, often Inactive asthma Asthma symptoms FIGURE 1 Summary of the asthma phenotypes identified using the latent class analysis. The phenotypes are plotted according to the characteristics that play a major role in their classification. The overlaps between the clusters are proportional to the estimated membership probabilities. As an example, subjects assigned to phenotype B had a mean posterior probability to belong to phenotype A, C and D of 7%, 7% and 2%, respectively. ASTHMA | V. SIROUX ET AL. DOI: 10.1183/09031936.00032713 collected in epidemiological surveys) was 82.4%, but varied widely between phenotypes (from 92.8% for phenotype A to 61.1% for phenotype D).
GWAS results
Manhattan plots of association results for each asthma phenotype are presented in figure 2. We detected two genome-wide significant associations between ''active adult-onset nonallergic asthma'' (phenotype D) and rs9851461 on chromosome 3, flanking CD200 (p59.4610 -9 ), and between ''inactive/mild nonallergic asthma'' (phenotype A) and rs2579931 on chromosome 6 in GRIK2 (p52.7610 -9 ) (table 3) . Based on the criteria of two consecutive SNPs at p,10 -6 , four chromosomal locations were detected. Pairwise LD measures between SNPs of each of these genes showing multiple signals are presented in table E4. Of the 11 SNPs, three belonging or flanking the ALCAM gene located on chromosome 3 were associated with phenotype D (active adult-onset nonallergic asthma; rs9842772, rs9288812 and rs1051124 with p-values of 2.5610 -7 , 6.6610 -7 and 8.2610 -7 , respectively). The two latter SNPs were not in strong LD with rs9842772 (r 2 50.39). Association signals were detected between phenotype A (inactive/mild non-allergic asthma) and four SNPs in LOC401410 on chromosome 7 (rs10264996, rs10259042, rs10230811 and rs17162196), two SNPs in LRRC6 on chromosome 8 (rs7834760 and rs13272108) and two SNPs in SBF2 on chromosome 11 (rs4576815 and rs7938647), with p-values ranging from 2.5610 -7 to 9.6610 -7 . All SNPs detected at p,10 -6 exhibited statistically significant heterogeneity of effects observed across the asthma phenotypes (p,0.002). GWAS on the other two asthma phenotypes did not provide prominent association signals (table 3) . None of the SNPs identified in our GWAS showed any trend for association with asthma in the GABRIEL (100) 328 (18) 648 (34) 533 (28) 386 (20) SAPALDIA 465 (100) 143 (31) 176 (38) 62 (13) 84 (18) EGEA 641 (100) 83 (13) 276 (43) 215 (34) 67 (10) ESE consortium 3001 (100) 554 (18) 1100 (37) 810 (27) 537 (18) The six loci detected at p,10 -6 in the present GWAS were investigated using imputed data ( fig. E3 ) and the analyses were conducted in the pooled sample as well as separately in each study ( fig. E4 ). Association signals were consistent across studies for all SNPs, except for rs9851461 flanking CD200 and the active adult-onset nonallergic asthma phenotype, showing stronger association in EGEA.
The two SNPs flanking ALCAM (rs9288812 and rs1051124) were significantly related to blood neutrophil counts, with the alleles associated with a greater risk for active adult-onset asthma (phenotype D) also being associated with an increased level of neutrophils (n5533, adjusted p-values50.01). No association was detected between these SNPs and blood neutrophils among subjects without asthma and between blood neutrophils and the two other SNPs reported for phenotype D. 1  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3  2  22  1  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3  2  22   1  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3  2  22  1  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3 Replication of SNPs identified in previous asthma GWAS 13 SNPs located in IL1RL1, IL18R1, DPP10, TSLP, RAD50-IL13, HLA-DQ, IL33, RORA, ORMDL3/GSDMB and IL12RB were replicated (p,0.01) with active allergic asthma (phenotype C), and heterogeneity of association across phenotypes was significant (p-value for heterogeneity f0.01) for eight SNPs located in IL1RL1, IL18R1, DPP10, TSLP, HLA-DQ and IL33 (table 4) . Six SNPs located in IL1RL1, HLA-DQ, IL33 and SMAD3 were significantly associated with inactive/mild allergic asthma (phenotye B). A single SNP in SRP9 (rs4653433) was associated with active adult-onset nonallergic asthma (phenotype D) (p-value for heterogeneity50.003). None of the 39 SNPs were associated with inactive/mild nonallergic asthma (phenotype A).
Discussion
Applying LCA, a model-based clustering approach, in a large sample of well-characterised subjects with asthma led to the identification of four asthma phenotypes, mainly characterised by disease activity, allergic status and age of asthma onset. Beside these main characteristics, sex, FEV1 and BHR also played a role in the classification. GWAS on each asthma phenotype revealed a gene of potential interest in active adultonset nonallergic asthma, ALCAM (activated leukocyte cell adhesion molecule), with evidence of heterogeneity of SNP effect across asthma phenotypes. All replication of asthma SNPs identified by previous GWAS (located in IL1RL1, SMAD3, RORA, ORMDL3/GSDMB, DPP10, TSLP, RAD50-IL13, HLA-DQ, IL33 and IL12RB) were observed with the allergic asthma phenotypes, except one belonging to the SRP9 gene found to be associated with active adult-onset nonallergic asthma. Taken together, our results support the hypothesis that a better understanding of the phenotypic heterogeneity of asthma may help to disentangle the genetic heterogeneity of asthma.
One strength of the study relates to the large sample of well-characterised adults with asthma, recruited in three epidemiological settings using standardised protocols and clinical examination, allowing identification of subgroups of subjects with shared characteristics of multiple disease features. As the results of the mostly population-based study designs, the population includes both persistent and remittent asthma, and the prevalence of severe asthma is low in this population. Interestingly, the asthma phenotypes identified by LCA conducted on the pooled EGEA2, ECRHSII and SAPALDIAII population with asthma were highly consistent with phenotypes previously identified separately in ECRHSII and EGEA2 [10] . As previously discussed [5, 10] , there are similarities with previous cluster-derived adult asthma phenotypes [8, 9] in the identification of a group of subjects with early-onset atopic asthma and groups of subjects with benign (mild) asthma. Furthermore, our phenotype D, mainly characterised by adult-onset nonatopic asthma, shows similarities to phenotype 5 described by MOORE et al. [8] (groups showing higher airflow limitation and exacerbation rate compared to the other phenotypes). Nevertheless, the phenotypes were defined at one time-point and further work is needed in the context of longitudinal data to also account for disease expression variability over time.
Although the phenotypic heterogeneity has been considered as a major limitation in understanding the genetic determinants of asthma, few studies have examined to what extent a better phenotypic resolution leads to identify new genetic determinants [3] . MOFFAT et al.
[1] previously applied this approach with a single asthma characteristic, age at asthma onset (childhood versus adult onset). LI et al. [17] performed a GWAS on a population of well-characterised patients with severe or difficult-to-treat asthma and identified the RAD50-IL13 region and the HLA DR/DQ region. These studies used stratification on a limited number of traditional phenotypic traits and thus may have had little opportunity to unravel new associations. Our study is the first to perform genetic analysis in a large population-based sample in which asthma phenotypes were obtained in an unsupervised manner by means of LCA.
The lack of formal replication of the genetic association signals detected by this GWAS approach is a limitation of our study. Nevertheless, the findings were supported by the association patterns observed within the region and the consistency of the association across studies. Replication is particularly challenging here, as there are very few large adult studies with similarly detailed phenotypic information that would enable generation of the phenotypes we have used. The low agreement between the LCA-derived asthma phenotypes and a simple classification based on atopy and the presence of asthma attacks in the past 12 months for phenotype D (active adult-onset nonallergic asthma) indicates that these two characteristics are not sufficient to suitably define this phenotype of major interest, given our GWAS results. Overall our GWAS association findings with specific asthma phenotypes have to be interpreted cautiously.
The sample size may be seen as a limitation of the study. However, this consideration of power has to be discussed taking into account the improved phenotypic characterisation accounting for the disease heterogeneity [30] . Large consortia on asthma genetics have been set up based on ''poor'' asthma phenotype definition, which, in the context of a highly heterogeneous disease, may explain part of the missing heritability as some genetic effects might be diluted as the result of phenotype missclassification [3] . The approach used in the present analysis, favouring phenotypic characterisation over sample size, could therefore provide complementary insights to large asthma genetic studies. This is, in part, supported by the lack of overlap between our GWAS results and the GABRIEL results. One limitation on the approach used lies in the difficulty to directly compare findings across studies, since cluster-based phenotypes differ between studies.
ALCAM, a member of the Ig superfamily, is a good asthma candidate gene. The ALCAM gene encodes the CD166 antigen and was originally identified as a transmembrane receptor that is involved in T-cell activation and may play a role in the binding of T-and B-cells to activated leukocytes. Altered expression of ALCAM has been associated with differentiation state and progression in many tumours [31] . More interestingly, ALCAM was identified as a common gene in three inflammatory diseases: Crohn's disease, rheumatoid arthritis and type 1 diabetes [32] . Furthermore, ALCAM interacts with ADAM17 (a disintegrin and metalloproteinase 17), which is implicated in immune cell development and function and has been shown to play a role in the epidermal barrier [33, 34] . Interestingly, a further SNP in the CD200 gene (CD200 molecule), located in the same genomic region as ALCAM and encoding a protein also belonging to the Ig superfamily, was exclusively associated with the active adult-onset asthma phenotype. Nevertheless, this result in CD200 should be interpreted cautiously because of the low minor allele frequency of the identified SNP. To date, there is no strong biological evidence to support the role of the four genes showing an association with inactive/mild nonallergic asthma (GRIK2 (glutamate receptor, ionotropic, kainate 2, 6q16.3) involved in neurophysiological processes; LOC401410 (7q34); LRRC6 (leucine-rich repeat containing 6, 8q24.22) , possibly involved in spermatocytogenesis; and SBF2 (SET-binding factor, 11p15.4), possibly involved in biological processes related to bone and muscle growth [35] ). The lack of hits with phenotype C might be explained by limited statistical power.
None of the variants identified in previous asthma GWAS meet the GWAS significance level in the present study. This might be explained by a lack of power of our study to identify shared genetic variants between phenotypes compared to previous asthma GWAS, which considered the whole group of subjects with asthma. Most of the replications (using the 0.01 threshold) were observed for the active allergic asthma phenotype, including SNPs in or near IL1RL1, IL18R1, DPP10, RAD50-IL13, HLA-DQ, IL33, RORA, ORMDL3/GSDMB and IL12RB. This may have occurred because childhood-onset asthma is more prone to association with allergic phenotypes, and has been more intensively investigated in previous asthma GWAS.
Our results are consistent with a specific role of SNPs in ORMDL3/GSDMB with childhood-onset asthma (stronger odds ratio observed with phenotype C), although the p-value for heterogeneity did not indicate marked differences between the described phenotypes (possibly because of our smaller sample size). Our results indicate a specific role of SNP rs1837253 in TSLP, a gene involved in the T-helper type-2 cell immune processes in the airways of subjects with asthma, in active asthma as supported by the heterogeneity in allelic odds ratios between phenotypes. This suggests that phenotypic heterogeneity may partly explain the genetic heterogeneity previously identified by the GABRIEL study for this SNP.
Our results support the hypothesis that a better understanding of the asthma phenotypic heterogeneity helps to disentangle the genetic heterogeneity of asthma. The genetic and environmental components of the aetiology of asthma may be clarified by considering specific asthma phenotypes.
